Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $10.2B | $11.3B | $12.8B | $13.9B | $14.2B | $15.5B | $18.4B | $19.8B | $21.2B | $25.0B | $25.8B | $30.4B | $38.8B | $40.6B | $33.9B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, AbbVie Inc.'s last 12-month Gross Profit is $42.7B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, AbbVie Inc.'s Gross Profit growth was 17.7%. The average annual Gross Profit growth rates for AbbVie Inc. have been 9.5% over the past three years, 10.9% over the past five years.
Over the last year, AbbVie Inc.'s Gross Profit growth was 17.7%, which is higher than industry growth of 0.3%. It indicates that AbbVie Inc.'s Gross Profit growth is Good.